Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
August 22, 2020
Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington's disease models
Michael A Mason, Casandra Gomez-Paredes, Kirupa Sathasivam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 27, 2008
DNA instability in postmitotic neurons
Roman Gonitel, Hilary Moffitt, Kirupa Sathasivam, et al.
Journal of Neurochemistry
|
November 8, 2007
Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease
Andreas Weiss, Corinna Klein, Ben Woodman, et al.
Brain Research Bulletin
|
March 14, 2007
The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes
Ben Woodman, Rachel Butler, Christian Landles, et al.
Annals of Neurology
|
August 2, 2003
Minocycline and doxycycline are not beneficial in a model of Huntington's disease
Donna L Smith, Benjamin Woodman, Amarbirpal Mahal, et al.
Molecular Medicine (Cambridge, Mass.)
|
April 10, 2024
Correction: Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues
Franziska Hoschek, Julia Natan, Maximilian Wagner, et al.
Molecular Medicine (Cambridge, Mass.)
|
March 8, 2024
Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues
Franziska Hoschek, Julia Natan, Maximilian Wagner, et al.
Human Molecular Genetics
|
October 15, 2009
Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease
Kirupa Sathasivam, Amin Lane, Justin Legleiter, et al.
Human Molecular Genetics
|
April 30, 2004
Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach
David G Hay, Kirupa Sathasivam, Sönke Tobaben, et al.
Brain Communications
|
December 23, 2024
Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays
Christian Landles, Georgina F Osborne, Jemima Phillips, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
August 22, 2020
Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington's disease models
Michael A Mason, Casandra Gomez-Paredes, Kirupa Sathasivam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 27, 2008
DNA instability in postmitotic neurons
Roman Gonitel, Hilary Moffitt, Kirupa Sathasivam, et al.
Journal of Neurochemistry
|
November 8, 2007
Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease
Andreas Weiss, Corinna Klein, Ben Woodman, et al.
Brain Research Bulletin
|
March 14, 2007
The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes
Ben Woodman, Rachel Butler, Christian Landles, et al.
Annals of Neurology
|
August 2, 2003
Minocycline and doxycycline are not beneficial in a model of Huntington's disease
Donna L Smith, Benjamin Woodman, Amarbirpal Mahal, et al.
Molecular Medicine (Cambridge, Mass.)
|
April 10, 2024
Correction: Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues
Franziska Hoschek, Julia Natan, Maximilian Wagner, et al.
Molecular Medicine (Cambridge, Mass.)
|
March 8, 2024
Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues
Franziska Hoschek, Julia Natan, Maximilian Wagner, et al.
Human Molecular Genetics
|
October 15, 2009
Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease
Kirupa Sathasivam, Amin Lane, Justin Legleiter, et al.
Human Molecular Genetics
|
April 30, 2004
Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach
David G Hay, Kirupa Sathasivam, Sönke Tobaben, et al.
Brain Communications
|
December 23, 2024
Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays
Christian Landles, Georgina F Osborne, Jemima Phillips, et al.
Page
of 3